{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:35:32Z","timestamp":1785540932029,"version":"3.56.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanxi Basic Research Program","award":["YDZJSX20231A063"],"award-info":[{"award-number":["YDZJSX20231A063"]}]},{"name":"the General Program of the National Natural Science Foundation of China","award":["201601D102067"],"award-info":[{"award-number":["201601D102067"]}]},{"name":"Soft Science Research in Shanxi Province","award":["2017041038-3"],"award-info":[{"award-number":["2017041038-3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-024-00646-8","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T10:04:43Z","timestamp":1722333883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Transcriptomics explores potential mechanisms for the development of Primary Sjogren\u2019s syndrome to diffuse large B-cell lymphoma in B cells"],"prefix":"10.1186","volume":"25","author":[{"given":"Yanan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,30]]},"reference":[{"issue":"11","key":"646_CR1","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","volume":"74","author":"B Qin","year":"2015","unstructured":"Qin B, Wang J, Yang Z, et al. Epidemiology of primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(11):1983\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"646_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","volume":"22","author":"S Negrini","year":"2022","unstructured":"Negrini S, Emmi G, Greco M, et al. Sj\u00f6gren\u2019s syndrome: a systemic autoimmune disease. Clin Exp Med. 2022;22(1):9\u201325.","journal-title":"Clin Exp Med"},{"issue":"20","key":"646_CR3","first-page":"354","volume":"114","author":"AL Stefanski","year":"2017","unstructured":"Stefanski AL, Tomiak C, Pleyer U, Dietrich T, Burmester GR, D\u00f6rner T. The diagnosis and treatment of Sj\u00f6gren\u2019s Syndrome. Dtsch Arztebl Int. 2017;114(20):354\u201361.","journal-title":"Dtsch Arztebl Int"},{"issue":"30","key":"646_CR4","doi-asserted-by":"publisher","first-page":"50098","DOI":"10.18632\/oncotarget.15100","volume":"8","author":"YH Chiu","year":"2017","unstructured":"Chiu YH, Chung CH, Lin KT, et al. Predictable biomarkers of developing lymphoma in patients with Sj\u00f6gren syndrome: a nationwide population-based cohort study. Oncotarget. 2017;8(30):50098\u2013108.","journal-title":"Oncotarget"},{"issue":"6","key":"646_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3322\/caac.21357","volume":"66","author":"LR Teras","year":"2016","unstructured":"Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016;66(6):443\u201359.","journal-title":"CA Cancer J Clin"},{"key":"646_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1146\/annurev-med-043015-123313","volume":"68","author":"CP Mavragani","year":"2017","unstructured":"Mavragani CP. Mechanisms and new strategies for primary Sj\u00f6gren\u2019s syndrome. Annu Rev Med. 2017;68:331\u201343.","journal-title":"Annu Rev Med"},{"issue":"4","key":"646_CR7","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/art.39518","volume":"68","author":"G Nocturne","year":"2016","unstructured":"Nocturne G, Virone A, Ng WF, et al. Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sj\u00f6gren\u2019s Syndrome. Arthritis Rheumatol (Hoboken, NJ). 2016;68(4):977\u201385.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"11","key":"646_CR8","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1182\/blood.2019001160","volume":"134","author":"CS Tam","year":"2019","unstructured":"Tam CS, Trotman J, Opat S, et al. Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL. Blood. 2019;134(11):851\u20139.","journal-title":"Blood"},{"issue":"1","key":"646_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13045-020-01011-z","volume":"13","author":"L Wang","year":"2020","unstructured":"Wang L, Li LR, Young KH. New agents and regimens for diffuse large B cell lymphoma. J Hematol Oncol. 2020;13(1):175.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"646_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/13543784.2021.1855140","volume":"30","author":"A Patriarca","year":"2021","unstructured":"Patriarca A, Gaidano G. Investigational drugs for the treatment of diffuse large B-cell lymphoma. Expert Opin Investig Drugs. 2021;30(1):25\u201338.","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"646_CR11","doi-asserted-by":"publisher","first-page":"e202009045","DOI":"10.1083\/jcb.202009045","volume":"220","author":"MC Bridges","year":"2021","unstructured":"Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA localization and function. J Cell Biol. 2021;220(2):e202009045.","journal-title":"J Cell Biol"},{"issue":"2","key":"646_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281\u201397.","journal-title":"Cell"},{"issue":"1","key":"646_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13075-016-1005-2","volume":"18","author":"H Shi","year":"2016","unstructured":"Shi H, Cao N, Pu Y, Xie L, Zheng L, Yu C. Long non-coding RNA expression profile in minor salivary gland of primary Sj\u00f6gren\u2019s syndrome. Arthritis Res Ther. 2016;18(1):109.","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"646_CR14","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/jop.13355","volume":"51","author":"Q Gao","year":"2022","unstructured":"Gao Q, Ye Z, Liu T, et al. Hsa-miR-3202 attenuates Jurkat cell infiltration via MMP2 in primary Sj\u00f6gren\u2019s syndrome. J Oral Pathol Med. 2022;51(9):818\u201328.","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"646_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","volume":"14","author":"G Nocturne","year":"2018","unstructured":"Nocturne G, Mariette X. B cells in the pathogenesis of primary Sj\u00f6gren syndrome. Nat Rev Rheumatol. 2018;14(3):133\u201345.","journal-title":"Nat Rev Rheumatol"},{"key":"646_CR16","doi-asserted-by":"publisher","first-page":"594658","DOI":"10.3389\/fimmu.2020.594658","volume":"11","author":"X Hong","year":"2020","unstructured":"Hong X, Meng S, Tang D, et al. Single-Cell RNA Sequencing Reveals the Expansion of Cytotoxic CD4+ T Lymphocytes and a Landscape of Immune Cells in Primary Sj\u00f6gren\u2019s Syndrome. Front Immunol. 2020;11:594658.","journal-title":"Front Immunol"},{"key":"646_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jaut.2017.11.003","volume":"87","author":"GM Verstappen","year":"2018","unstructured":"Verstappen GM, Corneth OBJ, Bootsma H, Kroese FGM. Th17 cells in primary Sj\u00f6gren\u2019s syndrome: Pathogenicity and plasticity. J Autoimmun. 2018;87:16\u201325.","journal-title":"J Autoimmun"},{"key":"646_CR18","doi-asserted-by":"publisher","first-page":"243723","DOI":"10.1155\/2015\/243723","volume":"2015","author":"A Alunno","year":"2015","unstructured":"Alunno A, Carubbi F, Bistoni O, et al. T Regulatory and T Helper 17 Cells in Primary Sj\u00f6gren\u2019s Syndrome: Facts and Perspectives. Mediators Inflamm. 2015;2015:243723.","journal-title":"Mediators Inflamm"},{"key":"646_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2147\/OARRR.S276727","volume":"12","author":"SW Utomo","year":"2020","unstructured":"Utomo SW, Putri JF. Infections as risk factor of Sj\u00f6gren\u2019s syndrome. Open Access Rheumatol. 2020;12:257\u201366.","journal-title":"Open Access Rheumatol"},{"issue":"6","key":"646_CR20","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/joim.12888","volume":"285","author":"J Mofors","year":"2019","unstructured":"Mofors J, Arkema EV, Bj\u00f6rk A, et al. Infections increase the risk of developing Sj\u00f6gren\u2019s syndrome. J Intern Med. 2019;285(6):670\u201380.","journal-title":"J Intern Med"},{"issue":"Database issue","key":"646_CR21","first-page":"D991","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets\u2013update. Nucleic ACIDS res. 2013;41(Database issue):D991-995.","journal-title":"Nucleic ACIDS res"},{"issue":"7247","key":"646_CR22","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nature07968","volume":"459","author":"M Compagno","year":"2009","unstructured":"Compagno M, Lim WK, Grunn A, et al. Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature. 2009;459(7247):717\u201321.","journal-title":"Nature"},{"issue":"1","key":"646_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13075-020-02248-2","volume":"22","author":"J Inamo","year":"2020","unstructured":"Inamo J, Suzuki K, Takeshita M, et al. Identification of novel genes associated with dysregulation of B cells in patients with primary Sj\u00f6gren\u2019s syndrome. Arthritis Res Ther. 2020;22(1):153.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"646_CR24","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1200\/JCO.2014.57.7080","volume":"33","author":"K Dybk\u00e6r","year":"2015","unstructured":"Dybk\u00e6r K, B\u00f8gsted M, Falgreen S, et al. Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis. J Clin Oncol. 2015;33(12):1379\u201388.","journal-title":"J Clin Oncol"},{"key":"646_CR25","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"issue":"D1","key":"646_CR26","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51(D1):D587-d592.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"646_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"646_CR28","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1093\/nar\/gky311","volume":"46","author":"M Franz","year":"2018","unstructured":"Franz M, Rodriguez H, Lopes C, et al. GeneMANIA update 2018. Nucleic Acids Res. 2018;46(W1):W60-w64.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"646_CR29","doi-asserted-by":"publisher","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","volume":"49","author":"SL Freshour","year":"2021","unstructured":"Freshour SL, Kiwala S, Cotto KC, et al. Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Res. 2021;49(D1):D1144-d1151.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"646_CR30","doi-asserted-by":"publisher","first-page":"D1013","DOI":"10.1093\/nar\/gky1010","volume":"47","author":"Z Huang","year":"2019","unstructured":"Huang Z, Shi J, Gao Y, et al. HMDD v3.0: a database for experimentally supported human microRNA-disease associations. Nucleic Acids Res. 2019;47(D1):D1013\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"646_CR31","doi-asserted-by":"publisher","first-page":"W234","DOI":"10.1093\/nar\/gkz240","volume":"47","author":"G Zhou","year":"2019","unstructured":"Zhou G, Soufan O, Ewald J, Hancock REW, Basu N, Xia J. NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 2019;47(W1):W234-w241.","journal-title":"Nucleic Acids Res"},{"key":"646_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol (Clifton, NJ). 2018;1711:243\u201359.","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"issue":"6","key":"646_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41584-021-00605-2","volume":"17","author":"GM Verstappen","year":"2021","unstructured":"Verstappen GM, Pringle S, Bootsma H, Kroese FGM. Epithelial-immune cell interplay in primary Sj\u00f6gren syndrome salivary gland pathogenesis. Nat Rev Rheumatol. 2021;17(6):333\u201348.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"646_CR34","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1158\/1078-0432.CCR-21-3140","volume":"28","author":"M Autio","year":"2022","unstructured":"Autio M, Leivonen SK, Br\u00fcck O, Karjalainen-Lindsberg ML, Pellinen T, Lepp\u00e4 S. Clinical impact of immune cells and their spatial interactions in diffuse large B-Cell Lymphoma Microenvironment. Clin Cancer Res. 2022;28(4):781\u201392.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"646_CR35","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/1756-185X.13800","volume":"23","author":"VR Gorodetskiy","year":"2020","unstructured":"Gorodetskiy VR, Probatova NA, Vasilyev VI. Characteristics of diffuse large B-cell lymphoma in patients with primary Sj\u00f6gren\u2019s syndrome. Int J Rheum Dis. 2020;23(4):540\u20138.","journal-title":"Int J Rheum Dis"},{"issue":"19","key":"646_CR36","doi-asserted-by":"publisher","first-page":"7034","DOI":"10.3390\/ijms21197034","volume":"21","author":"E Butturini","year":"2020","unstructured":"Butturini E, de CarcereriPrati A, Mariotto S. Redox Regulation of STAT1 and STAT3 Signaling. Int J Mol Sci. 2020;21(19):7034.","journal-title":"Int J Mol Sci"},{"issue":"25","key":"646_CR37","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","volume":"127","author":"J Toubiana","year":"2016","unstructured":"Toubiana J, Okada S, Hiller J, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood. 2016;127(25):3154\u201364.","journal-title":"Blood"},{"key":"646_CR38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.clim.2016.03.010","volume":"165","author":"M Pertovaara","year":"2016","unstructured":"Pertovaara M, Silvennoinen O, Isom\u00e4ki P. Cytokine-induced STAT1 activation is increased in patients with primary Sj\u00f6gren\u2019s syndrome. Clin Immunol (Orlando, Fla). 2016;165:60\u20137.","journal-title":"Clin Immunol (Orlando, Fla)"},{"issue":"3","key":"646_CR39","first-page":"31","volume":"36 Suppl 112","author":"YJ Ha","year":"2018","unstructured":"Ha YJ, Choi YS, Kang EH, et al. Increased expression of interferon-\u03bb in minor salivary glands of patients with primary Sj\u00f6gren\u2019s syndrome and its synergic effect with interferon-\u03b1 on salivary gland epithelial cells. Clin Exp Rheumatol. 2018;36 Suppl 112(3):31\u201340.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"646_CR40","doi-asserted-by":"publisher","first-page":"e002694","DOI":"10.1136\/rmdopen-2022-002694","volume":"9","author":"Q Zheng","year":"2023","unstructured":"Zheng Q, Liu L, Wang B, He Y, Zhang M, Shi G. Phosphorylated signal transducer and activator of transcription proteins 1 in salivary glandular tissue: an important histological marker for diagnosis of primary Sj\u00f6gren\u2019s syndrome. RMD Open. 2023;9(1):e002694.","journal-title":"RMD Open"},{"issue":"5","key":"646_CR41","doi-asserted-by":"publisher","first-page":"e12662","DOI":"10.1111\/sji.12662","volume":"87","author":"J Imgenberg-Kreuz","year":"2018","unstructured":"Imgenberg-Kreuz J, Sandling JK, Bj\u00f6rk A, et al. Transcription profiling of peripheral B cells in antibody-positive primary Sj\u00f6gren\u2019s syndrome reveals upregulated expression of CX3CR1 and a type I and type II interferon signature. Scand J Immunol. 2018;87(5):e12662.","journal-title":"Scand J Immunol"},{"issue":"8","key":"646_CR42","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41374-020-0453-0","volume":"101","author":"H Wu","year":"2021","unstructured":"Wu H, Chen X, Gu F, et al. CP-25 alleviates antigen-induced experimental Sj\u00f6gren\u2019s syndrome in mice by inhibiting JAK1-STAT1\/2-CXCL13 signaling and interfering with B-cell migration. Lab Investig J Tech Methods Pathol. 2021;101(8):1084\u201397.","journal-title":"Lab Investig J Tech Methods Pathol"},{"key":"646_CR43","doi-asserted-by":"publisher","unstructured":"Casares-Marfil D, Mart\u00ednez-Bueno M, Borghi MO, et al. A genome-wide association study suggests new susceptibility loci for primary antiphospholipid syndrome. Arthritis Rheumatology (Hoboken, NJ). 2024. https:\/\/doi.org\/10.1002\/art.42947.","DOI":"10.1002\/art.42947"},{"key":"646_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2024.103243","volume":"147","author":"J Ritter","year":"2024","unstructured":"Ritter J, Szelinski F, Aue A, et al. Elevated unphosphorylated STAT1 and IRF9 in T and B cells of primary sj\u00f6gren\u2019s syndrome: Novel biomarkers for disease activity and subsets. J Autoimmun. 2024;147: 103243.","journal-title":"J Autoimmun"},{"issue":"5","key":"646_CR45","doi-asserted-by":"publisher","first-page":"C1494","DOI":"10.1152\/ajpcell.00661.2023","volume":"326","author":"X Chen","year":"2024","unstructured":"Chen X, Li M, Li H, Liu M, Su J, Ji Y. Implications of IFN\u03b3 SNP rs2069705 in primary Sj\u00f6gren\u2019s syndrome: transcriptional activation and B cell infiltration. Am J Physiol Cell Physiol. 2024;326(5):C1494-c1504.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"Pt 9","key":"646_CR46","first-page":"1969","volume":"126","author":"R Camicia","year":"2013","unstructured":"Camicia R, Bachmann SB, Winkler HC, et al. BAL1\/ARTD9 represses the anti-proliferative and pro-apoptotic IFN\u03b3-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma. J Cell Sci. 2013;126(Pt 9):1969\u201380.","journal-title":"J Cell Sci"},{"issue":"1","key":"646_CR47","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41392-022-00895-2","volume":"7","author":"R Sun","year":"2022","unstructured":"Sun R, Zhang PP, Weng XQ, et al. Therapeutic targeting miR130b counteracts diffuse large B-cell lymphoma progression via OX40\/OX40L-mediated interaction with Th17 cells. Signal Transduct Target Ther. 2022;7(1):80.","journal-title":"Signal Transduct Target Ther"},{"key":"646_CR48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12943-015-0474-2","volume":"14","author":"R Camicia","year":"2015","unstructured":"Camicia R, Winkler HC, Hassa PO. Novel drug targets for personalized precision medicine in relapsed\/refractory diffuse large B-cell lymphoma: a comprehensive review. Mol Cancer. 2015;14:207.","journal-title":"Mol Cancer"},{"key":"646_CR49","doi-asserted-by":"crossref","unstructured":"Xu X, Zhang Y, Lu Y, et al. CD58 alterations govern antitumor immune responses by inducing PD-L1 and IDO in diffuse large B-cell lymphoma. Cancer Res. 2024;84 (13):2123\u201340.","DOI":"10.1158\/0008-5472.CAN-23-2874"},{"key":"646_CR50","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.3389\/fimmu.2019.02814","volume":"10","author":"A Charras","year":"2019","unstructured":"Charras A, Arvaniti P, Le Dantec C, et al. JAK inhibitors and oxidative stress control. Front Immunol. 2019;10:2814.","journal-title":"Front Immunol"},{"issue":"6","key":"646_CR51","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/2211-5463.13382","volume":"12","author":"S Deymier","year":"2022","unstructured":"Deymier S, Louvat C, Fiorini F, Cimarelli A. ISG20: an enigmatic antiviral RNase targeting multiple viruses. FEBS Open Bio. 2022;12(6):1096\u2013111.","journal-title":"FEBS Open Bio"},{"issue":"6","key":"646_CR52","doi-asserted-by":"publisher","first-page":"e49568","DOI":"10.15252\/embr.201949568","volume":"22","author":"D Stadler","year":"2021","unstructured":"Stadler D, K\u00e4chele M, Jones AN, et al. Interferon-induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20. EMBO Rep. 2021;22(6):e49568.","journal-title":"EMBO Rep"},{"issue":"24","key":"646_CR53","doi-asserted-by":"publisher","first-page":"7174","DOI":"10.1021\/bi010141t","volume":"40","author":"LH Nguyen","year":"2001","unstructured":"Nguyen LH, Espert L, Mechti N, Wilson DM 3rd. The human interferon- and estrogen-regulated ISG20\/HEM45 gene product degrades single-stranded RNA and DNA in vitro. Biochemistry. 2001;40(24):7174\u20139.","journal-title":"Biochemistry"},{"issue":"4","key":"646_CR54","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783\u2013801.","journal-title":"Cell"},{"issue":"11","key":"646_CR55","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11926-021-01047-1","volume":"23","author":"AB Satterthwaite","year":"2021","unstructured":"Satterthwaite AB. TLR7 Signaling in Lupus B Cells: New Insights into Synergizing Factors and Downstream Signals. Curr Rheumatol Rep. 2021;23(11):80.","journal-title":"Curr Rheumatol Rep"},{"issue":"7782","key":"646_CR56","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-019-1612-6","volume":"575","author":"O Majer","year":"2019","unstructured":"Majer O, Liu B, Kreuk LSM, Krogan N, Barton GM. UNC93B1 recruits syntenin-1 to dampen TLR7 signalling and prevent autoimmunity. Nature. 2019;575(7782):366\u201370.","journal-title":"Nature"},{"issue":"7909","key":"646_CR57","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","volume":"605","author":"GJ Brown","year":"2022","unstructured":"Brown GJ, Ca\u00f1ete PF, Wang H, et al. TLR7 gain-of-function genetic variation causes human lupus. Nature. 2022;605(7909):349\u201356.","journal-title":"Nature"},{"key":"646_CR58","doi-asserted-by":"publisher","first-page":"637659","DOI":"10.3389\/fimmu.2021.637659","volume":"12","author":"S Zhang","year":"2021","unstructured":"Zhang S, Qu J, Wang L, et al. Activation of Toll-Like Receptor 7 Signaling Pathway in Primary Sj\u00f6gren\u2019s Syndrome-Associated Thrombocytopenia. Front Immunol. 2021;12:637659.","journal-title":"Front Immunol"},{"key":"646_CR59","doi-asserted-by":"publisher","first-page":"1034336","DOI":"10.3389\/fimmu.2022.1034336","volume":"13","author":"A Punnanitinont","year":"2022","unstructured":"Punnanitinont A, Kasperek EM, Kiripolsky J, Zhu C, Miecznikowski JC, Kramer JM. TLR7 agonism accelerates disease in a mouse model of primary Sj\u00f6gren\u2019s syndrome and drives expansion of T-bet(+) B cells. Front Immunol. 2022;13:1034336.","journal-title":"Front Immunol"},{"issue":"6","key":"646_CR60","doi-asserted-by":"publisher","first-page":"e01914","DOI":"10.1128\/JVI.01914-17","volume":"92","author":"T Yogarajah","year":"2018","unstructured":"Yogarajah T, Ong KC, Perera D, Wong KT. RSAD2 and AIM2 Modulate Coxsackievirus A16 and Enterovirus A71 Replication in Neuronal Cells in Different Ways That May Be Associated with Their 5\u2019 Nontranslated Regions. J Virol. 2018;92(6):e01914-17.","journal-title":"J Virol"},{"issue":"5","key":"646_CR61","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1007\/s11010-021-04070-z","volume":"476","author":"H Zhu","year":"2021","unstructured":"Zhu H, Zheng J, Zhou Y, Wu T, Zhu T. Knockdown of RSAD2 attenuates B cell hyperactivity in patients with primary Sj\u00f6gren\u2019s syndrome (pSS) via suppressing NF-\u03bab signaling pathway. Mol Cell Biochem. 2021;476(5):2029\u201337.","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"646_CR62","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/annrheumdis-2016-209589","volume":"76","author":"NI Maria","year":"2017","unstructured":"Maria NI, Steenwijk EC, IJpma AS, et al. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 2017;76(4):721\u201330.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"646_CR63","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.tim.2017.01.001","volume":"25","author":"W Wang","year":"2017","unstructured":"Wang W, Xu L, Su J, Peppelenbosch MP, Pan Q. Transcriptional Regulation of Antiviral Interferon-Stimulated Genes. Trends Microbiol. 2017;25(7):573\u201384.","journal-title":"Trends Microbiol"},{"issue":"6","key":"646_CR64","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1093\/rheumatology\/key360","volume":"60","author":"ILA Bodewes","year":"2021","unstructured":"Bodewes ILA, Bj\u00f6rk A, Versnel MA, Wahren-Herlenius M. Innate immunity and interferons in the pathogenesis of Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford). 2021;60(6):2561\u201373.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"646_CR65","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1586\/1744666X.2014.876364","volume":"10","author":"Z Brkic","year":"2014","unstructured":"Brkic Z, Versnel MA. Type I IFN signature in primary Sj\u00f6gren\u2019s syndrome patients. Expert Rev Clin Immunol. 2014;10(4):457\u201367.","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"646_CR66","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cytogfr.2007.10.006","volume":"19","author":"P Fitzgerald-Bocarsly","year":"2008","unstructured":"Fitzgerald-Bocarsly P, Dai J, Singh S. Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev. 2008;19(1):3\u201319.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"646_CR67","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/biom11020251","volume":"11","author":"N Del Papa","year":"2021","unstructured":"Del Papa N, Minniti A, Lorini M, et al. The Role of Interferons in the Pathogenesis of Sj\u00f6gren\u2019s Syndrome and Future Therapeutic Perspectives. Biomolecules. 2021;11(2):251.","journal-title":"Biomolecules"},{"issue":"3","key":"646_CR68","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cytogfr.2013.04.003","volume":"24","author":"FB Vincent","year":"2013","unstructured":"Vincent FB, Saulep-Easton D, Figgett WA, Fairfax KA, Mackay F. The BAFF\/APRIL system: emerging functions beyond B cell biology and autoimmunity. Cytokine Growth Factor Rev. 2013;24(3):203\u201315.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"646_CR69","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.canlet.2004.11.054","volume":"225","author":"A Oehadian","year":"2005","unstructured":"Oehadian A, Koide N, Mu MM, et al. Interferon (IFN)-beta induces apoptotic cell death in DHL-4 diffuse large B cell lymphoma cells through tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Cancer Lett. 2005;225(1):85\u201392.","journal-title":"Cancer Lett"},{"key":"646_CR70","doi-asserted-by":"publisher","first-page":"2137538","DOI":"10.1155\/2019\/2137538","volume":"2019","author":"AV Marangon","year":"2019","unstructured":"Marangon AV, Colli CM, Cardozo DM, et al. Impact of SNPs\/Haplotypes of IL10 and IFNG on the Development of Diffuse Large B-Cell Lymphoma. J Immunol Res. 2019;2019:2137538.","journal-title":"J Immunol Res"},{"issue":"5","key":"646_CR71","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/BOR.0000000000000622","volume":"31","author":"M Ma\u015bli\u0144ska","year":"2019","unstructured":"Ma\u015bli\u0144ska M. The role of Epstein-Barr virus infection in primary Sj\u00f6gren\u2019s syndrome. Curr Opin Rheumatol. 2019;31(5):475\u201383.","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"646_CR72","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/path.4459","volume":"235","author":"M Vockerodt","year":"2015","unstructured":"Vockerodt M, Yap LF, Shannon-Lowe C, et al. The Epstein-Barr virus and the pathogenesis of lymphoma. J Pathol. 2015;235(2):312\u201322.","journal-title":"J Pathol"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-024-00646-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-024-00646-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-024-00646-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T10:05:38Z","timestamp":1722333938000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-024-00646-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["646"],"URL":"https:\/\/doi.org\/10.1186\/s12865-024-00646-8","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,30]]},"assertion":[{"value":"25 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data and methods of the study were performed according to the ethical standards of the Second Hospital of Shanxi Medical University, and all participants agreed to participate in this study. This study was approved by the Ethics Committee of the Second Hospital of Shanxi Medical University which was carried out in accordance with the Declaration of Helsinki (protocol code: (2023)YX(161), date of approval: 27th April 2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All study participants have given their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}